Key Details
Annual ROE
28.35%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
May 23, 2023Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with EUCR included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Eucrates Biomedical Acquisition doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Eucrates Biomedical Acquisition?
- What is the ticker symbol for Eucrates Biomedical Acquisition?
- Does Eucrates Biomedical Acquisition pay dividends?
- What sector is Eucrates Biomedical Acquisition in?
- What industry is Eucrates Biomedical Acquisition in?
- What country is Eucrates Biomedical Acquisition based in?
- When did Eucrates Biomedical Acquisition go public?
- Is Eucrates Biomedical Acquisition in the S&P 500?
- Is Eucrates Biomedical Acquisition in the NASDAQ 100?
- Is Eucrates Biomedical Acquisition in the Dow Jones?
- When was Eucrates Biomedical Acquisition's last earnings report?
- When does Eucrates Biomedical Acquisition report earnings?
What is the primary business of Eucrates Biomedical Acquisition?
Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.
What is the ticker symbol for Eucrates Biomedical Acquisition?
The ticker symbol for Eucrates Biomedical Acquisition is NASDAQ:EUCR
Does Eucrates Biomedical Acquisition pay dividends?
No, Eucrates Biomedical Acquisition does not pay dividends
What sector is Eucrates Biomedical Acquisition in?
Eucrates Biomedical Acquisition is in the Financial Services sector
What industry is Eucrates Biomedical Acquisition in?
Eucrates Biomedical Acquisition is in the Shell Companies industry
What country is Eucrates Biomedical Acquisition based in?
Eucrates Biomedical Acquisition is headquartered in United States
When did Eucrates Biomedical Acquisition go public?
Eucrates Biomedical Acquisition's initial public offering (IPO) was on 28 December 2020
Is Eucrates Biomedical Acquisition in the S&P 500?
No, Eucrates Biomedical Acquisition is not included in the S&P 500 index
Is Eucrates Biomedical Acquisition in the NASDAQ 100?
No, Eucrates Biomedical Acquisition is not included in the NASDAQ 100 index
Is Eucrates Biomedical Acquisition in the Dow Jones?
No, Eucrates Biomedical Acquisition is not included in the Dow Jones index
When was Eucrates Biomedical Acquisition's last earnings report?
Eucrates Biomedical Acquisition's most recent earnings report was on 23 May 2023
When does Eucrates Biomedical Acquisition report earnings?
The date for Eucrates Biomedical Acquisition's next earnings report has not been announced yet